Stock Gains Accelerate as Remdesivir Treatment Approved in Japan
Stock Gains Accelerate as Remdesivir Treatment Approved in Japan

Positive signals from economic data and earnings paired with news on Gilead's remdesivir treatment helped to bolster stocks.